We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Aptiv Solutions Stock

Invest in or calculate the value of your shares in Aptiv Solutions or other pre-IPO companies through EquityZen's platform.

Get Started

Aptiv Solutions Stock

Aptiv is a biopharmaceutical and medical device company that offers a variety of clinical trial services.

About Aptiv Solutions Stock

Founded

1983

Headquarters

Reston, VA, US

Total Funding

5.7M

Industries

Software, Artificial Intelligence, Data and Analytics

Aptiv Solutions, Inc. operates as a clinical research organization that offers clinical trial services. The company also provides adaptive trial design, simulation, and execution; early phase development consulting; pre clinical development; and drug development services. The company also provides regulatory compliance consulting services, which include strategy development, agency advisory, legal representation, and submission management services. It also offers therapeutic services in the areas of oncology, cardiology, dermatology, respiratory, and orphan diseases. Further, the company develops AptivAdvantage, an integrated technology platform for the implementation and execution of adaptive clinical trials. Aptiv Solutions, Inc. was formerly known as Averion International Corp. and changed its name to Aptiv Solutions, Inc. in February 2011. The company was founded in 1983 and is based in Reston, Virginia with an office in Durham, North Carolina.

Aptiv Solutions Management

Leadership team at Aptiv Solutions

Executive VP & COO

Michael McKelvey

Chairman and CEO

Patrick K. Donnelly

Locked Features

Join now and verify your accreditation status to gain access to:

  • Aptiv Solutions current valuation
  • Aptiv Solutions stock price
  • Available deals in Aptiv Solutions and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Aptiv Solutions stock?

Accredited investors can buy pre-IPO stock in companies like Aptiv Solutions through EquityZen funds. These investments are made available by existing Aptiv Solutions shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Aptiv Solutions stock?

Shareholders can sell their Aptiv Solutions stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."